Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects

NCT06902090 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Meloxicam Nanocrystal Injection(Yangtze River Pharmaceutical Group Co., Ltd.)
DRUG: Meloxicam Nanocrystal Injection (ANJESO®)

Sponsor

Yangtze River Pharmaceutical Group Co., Ltd.